What’s New in Ontosight® Terminal 1 . 1
Partex Accelerates Antibody Engineering for Neurodegenerative Diseases Using NVIDIA-Accelerated AI / ML Platform
Partex and Ark Biopharmaceutical Expand Strategic Collaboration with New Out-Licensing Agreement for ATR Inhibitor AK0658
Partex wins Horizon Interactive Gold Award for Curia App
Try now
